HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Sodium influx plays a major role in the membrane depolarization induced by oxygen and glucose deprivation in rat striatal spiny neurons.

AbstractBACKGROUND AND PURPOSE:
Striatal spiny neurons are selectively vulnerable to ischemia, but the ionic mechanisms underlying this selective vulnerability are unclear. Although a possible involvement of sodium and calcium ions has been postulated in the ischemia-induced damage of rat striatal neurons, the ischemia-induced ionic changes have never been analyzed in this neuronal subtype.
METHODS:
We studied the effects of in vitro ischemia (oxygen and glucose deprivation) at the cellular level using intracellular recordings and microfluorometric measurements in a slice preparation. We also used various channel blockers and pharmacological compounds to characterize the ischemia-induced ionic conductances.
RESULTS:
Spiny neurons responded to ischemia with a membrane depolarization/inward current that reversed at approximately -40 mV. This event was coupled with an increased membrane conductance. The simultaneous analysis of membrane potential changes and of variations in [Na+]i and [Ca2+]i levels showed that the ischemia-induced membrane depolarization was associated with an increase of [Na+]i and [Ca2+]i. The ischemia-induced membrane depolarization was not affected by tetrodotoxin or by glutamate receptor antagonists. Neither intracellular BAPTA, a Ca2+ chelator, nor incubation of the slices in low-Ca2+-containing solutions affected the ischemia-induced depolarization, whereas it was reduced by lowering the external Na+ concentration. High doses of blockers of ATP-dependent K+ channels increased the membrane depolarization observed in spiny neurons during ischemia.
CONCLUSIONS:
Our findings show that, although the ischemia-induced membrane depolarization is coupled with a rise of [Na+]i and [Ca2+]i, only the Na+ influx plays a prominent role in this early electrophysiological event, whereas the increase of [Ca2+]i might be relevant for the delayed neuronal death. We also suggest that the activation of ATP-dependent K+ channels might counteract the ischemia-induced membrane depolarization.
AuthorsP Calabresi, G A Marfia, D Centonze, A Pisani, G Bernardi
JournalStroke (Stroke) Vol. 30 Issue 1 Pg. 171-9 (Jan 1999) ISSN: 0039-2499 [Print] United States
PMID9880406 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Calcium Channel Blockers
  • Calcium Channels
  • Chelating Agents
  • Hypoglycemic Agents
  • Potassium Channel Blockers
  • Potassium Channels
  • Receptors, Glutamate
  • Sodium Channel Blockers
  • Sodium Channels
  • Tetrodotoxin
  • Egtazic Acid
  • Adenosine Triphosphate
  • Tolbutamide
  • Sodium
  • Magnesium
  • Glucose
  • 1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid
  • Oxygen
  • Glyburide
  • Calcium
Topics
  • Adenosine Triphosphate (physiology)
  • Animals
  • Brain Ischemia (metabolism)
  • Calcium (metabolism, pharmacology)
  • Calcium Channel Blockers (pharmacology)
  • Calcium Channels (physiology)
  • Cerebral Cortex (blood supply, cytology)
  • Chelating Agents (pharmacology)
  • Corpus Striatum (blood supply, cytology)
  • Egtazic Acid (analogs & derivatives, pharmacology)
  • Glucose (pharmacology)
  • Glyburide (pharmacology)
  • Hypoglycemic Agents (pharmacology)
  • Magnesium (pharmacology)
  • Membrane Potentials (drug effects, physiology)
  • Neurons (chemistry, drug effects, physiology)
  • Organ Culture Techniques
  • Oxygen (pharmacology)
  • Patch-Clamp Techniques
  • Potassium Channel Blockers
  • Potassium Channels (physiology)
  • Rats
  • Rats, Wistar
  • Receptors, Glutamate (physiology)
  • Sodium (metabolism, pharmacokinetics)
  • Sodium Channel Blockers
  • Sodium Channels (physiology)
  • Tetrodotoxin (pharmacology)
  • Tolbutamide (pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: